Moving Beyond PM2.5 Mass to More Effectively Protect Health

[1]  M. Rosenfeld,et al.  Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole Genome Analysis of 7,840 Patients. , 2023, American journal of respiratory and critical care medicine.

[2]  A. Schneider,et al.  Impact of Ambient Ultrafine Particles on Cause-Specific Mortality in Three German Cities , 2023, American journal of respiratory and critical care medicine.

[3]  A. Cohen,et al.  Pollution and health: a progress update. , 2022, The Lancet. Planetary health.

[4]  G. Ewart,et al.  Excess Morbidity and Mortality Associated with Air Pollution above American Thoracic Society Recommended Standards, 2017-2019. , 2021, Annals of the American Thoracic Society.

[5]  I. Fajac,et al.  Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators , 2021, Cells.

[6]  M. Drumm,et al.  Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation , 2020, PloS one.

[7]  Agus Dwi Susanto,et al.  Air pollution and human health , 2020, Medical Journal of Indonesia.

[8]  T. To,et al.  Air Pollution and Noncommunicable Diseases: A Review by the Forum of International Respiratory Societies' Environmental Committee, Part 1: The Damaging Effects of Air Pollution. , 2019, Chest.

[9]  D. Postma,et al.  Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. , 2016, The New England journal of medicine.

[10]  J. Rommens,et al.  Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis , 2015, Nature Communications.

[11]  A. Harris,et al.  Ets homologous factor regulates pathways controlling response to injury in airway epithelial cells , 2014, Nucleic acids research.

[12]  Jin Kuk Yang,et al.  Structural and biochemical basis for the inhibition of cell death by APIP, a methionine salvage enzyme , 2013, Proceedings of the National Academy of Sciences.

[13]  M. Corey,et al.  A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies , 2011, Pediatric pulmonology.

[14]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[15]  A. Hamosh,et al.  Heritability of lung disease severity in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[16]  Jonathan D. Campbell,et al.  Disease-specific reference equations for lung function in patients with cystic fibrosis. , 2005, American journal of respiratory and critical care medicine.

[17]  D. Dockery,et al.  Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. , 1995, American journal of respiratory and critical care medicine.

[18]  G. Thurston,et al.  Associations between 1980 U.S. mortality rates and alternative measures of airborne particle concentration. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.

[19]  D. O. Hinton.  EPA Inhalable Particulate Network Report , 1986 .

[20]  J. Mead,et al.  Variability of maximum expiratory flow-volume curves. , 1974, Journal of applied physiology.

[21]  U. Epa.  Air Quality Criteria for Particulate Matter , 1996 .

[22]  J. Riordan.  Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA , 1989 .

[23]  B. Kerem.  Identification of the cystic fibrosis gene: genetic analysis , 1989 .